Prosztatarák: vizsgálatok itt: Franciaország
110 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Angers, Bordeaux, Bron, Clermont-Ferrand, Paris, Rouen, Saint-Cloud, Saint-Herblain Cedex
- Életkor
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Bordeaux, Brest Cedex 2, Clermont Ferrand Cedex1, Lille, Lyon, Paris, Strasbourg Cedex 2, Suresnes, Villejuif
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Bordeaux, Caen, Clermont-Ferrand, Le Mans, Lyon, Nice, Paris, Strasbourg, Suresnes, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisNot yet taking people in FranciaországAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 1/2. fázisTaking peopleA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Where
- Bordeaux, Clermont-Ferrand, Nantes, Villejuif
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07226986 · EU 2025-521859-23-00 - 3. fázisNot yet taking people in FranciaországSaruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Where
- Angers, Caen Cedex 5, Montpellier Cedex 5, Paris, Poitiers, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 1330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00 - 3. fázisTaking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Angers, Bordeaux, Caen Cedex 5, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, Paris, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Herblain Cedex, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Suresnes, Tours Cedex 9, Vandouvre Les Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - 3. fázisFut, nem toborozThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Where
- Angers, Bayonne, Besançon, Bordeaux, Brest, Creteil Cedex, La Roche Sur Yon Cedex 9, Lyon, Nice Cedex 2, Pierre-Bénite, Reims, Villejuif
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00 - 1/2. fázisFut, nem toborozA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Where
- Angers, Bayonne, Bordeaux, Lille, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06863272 · EU 2024-516036-94-00 - 1/2. fázisTaking peopleAn Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Where
- Besancon Cedex, Bordeaux, Dijon, Paris
- Életkor
- 18 év and over
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07206056 · EU 2025-521880-10-00 - 2. fázisFut, nem toborozRandomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
- Where
- Avignon, Besancon Cedex, Bordeaux, Brest, Lille, Marseille, Saint-Grégoire, St Herblain, Toulouse Cedex 3, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 62
- Run by
- Institut Bergonié
See details and how to joinNCT05346848 · EU 2023-509494-23-00 - No phaseTaking peopleBenchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
- Where
- Boulogne-Billancourt, Paris
- Életkor
- 18 év and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121 - 2. fázisTaking peopleTalazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer
- Where
- Bordeaux, Brest, Lille, Paris, Strasbourg Cedex, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Fundacion Oncosur
See details and how to joinNCT06582628 · EU 2023-510536-37-00 - 1. fázisTaking peoplePhase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Where
- Paris, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193 - 1/2. fázisTaking peopleA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- Where
- Lyon, Villejuif
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06990880 · EU 2025-521581-10-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Bordeaux, Clermont-Ferrand, Lyon, Nîmes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 3. fázisTaking peopleScreening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- Where
- Martigues
- Életkor
- 50 év to 70 év
- People
- 1284 worldwide
- Run by
- University of Alberta
See details and how to joinNCT06626022 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Bordeaux, Lyon, Suresnes
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1. fázisNot yet taking people in FranciaországPhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Lyon, Marseille, Toulouse Cedex 9
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 1. fázisTaking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Lyon, Paris, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseNot yet taking people in FranciaországTargeted And Perilesional Or Systematic Biopsy In Prostate Cancer
- Where
- Bordeaux, Marseille, Mont-de-Marsan, Paris, Quint-Fonsegrives
- Életkor
- 18 év and over
- People
- 456
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07296042 - No phaseTaking peopleDevelopment of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 100
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07820566 - 4. fázisNot yet taking people in FranciaországRandomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
- Where
- Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
- Életkor
- 65 év and over
- People
- 794
- Run by
- Institut Gustave Roussy
See details and how to join2025-523610-83-00